Cas:64460-41-9 Pyridin-4-ylmethanamine hydrochloride manufacturer & supplier

We serve Chemical Name:Pyridin-4-ylmethanamine hydrochloride CAS:64460-41-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Pyridin-4-ylmethanamine hydrochloride

Chemical Name:Pyridin-4-ylmethanamine hydrochloride
CAS.NO:64460-41-9
Synonyms:1-(4-Pyridinyl)methanamine hydrochloride (1:1);4-Pyridinemethanamine, hydrochloride (1:1);pyridin-4-ylmethanamine,hydrochloride;1-(Pyridin-4-yl)methanamine hydrochloride (1:1)
Molecular Formula:C6H9ClN2
Molecular Weight:144.602
HS Code:2933399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:230ºC at 760 mmHg
Density:N/A
Index of Refraction:
PSA:38.91000
Exact Mass:144.045425
LogP:2.04260

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-(4-Pyridinyl)methanamine hydrochloride (1:1) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(Pyridin-4-yl)methanamine hydrochloride (1:1) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(4-Pyridinyl)methanamine hydrochloride (1:1) Use and application,4-Pyridinemethanamine, hydrochloride (1:1) technical grade,usp/ep/jp grade.


Related News: The CHMP has agreed on an update of recommendations for monitoring patients. Healthcare professionals should now check their patients for signs of blood cancers at least once a year for 15 years.1 methyl 2-(quinuclidin-3-yl)acetate manufacturers He said it is “normal” for scientists and clinicians to discuss and debate data from experiments and clinical trials, but added those discussions have taken a turn “outside the boundaries of legitimate scientific deliberation.” Benzoic acid, 3-methoxy-, 3′-(aminocarbonyl)[1,1′-biphenyl]-4-yl ester suppliers The jury unanimously ruled in Plexxikon’s favor on all seven questions, including that Novartis has not proved the specification of the patent was full and clear enough to enable a person of “ordinary skill” to make and use the invention. 2,3-Dimethoxy-6-formyl-benzoesaeure-(N,N-dimethyl)-amid vendor & factory.